I-Mab announced certain management and personnel changes. Pamela Klein, M.D., has accepted the appointment as the Interim Chairperson of the Company, as Jingwu Zang, M.D., Ph.D., steps down from the Board, effective February 10, 2024, to lead the Hangzhou Company. Andrew Zhu, M.D., Ph.D., will step down from the Board and resign from his executive position with the Company, effective February 10, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.78 USD | -1.66% | +1.14% | -6.32% |
04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
04-15 | I-Mab Announces Chief Medical Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.32% | 144M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
-2.71% | 159B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- I-Mab Announces Board Changes , Effective February 10, 2024